New solutions are needed for the six million people in the US affected by anaemia of chronic kidney disease.... Jul 17
GSK plc today announced positive headline results from five studies of the Phase 3 ASCEND programme, for patients with anaemia due to chronic kidney disease (... Jul 17
-Advertisements-